Loading…

Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case

We propose a stochastic model for the drug concentration in the case of multiple oral doses and in a situation of poor patient adherence. Our model is able to take into account an irregular drug intake schedule. This article is the second in a series of three. It presents a multi-oral version of the...

Full description

Saved in:
Bibliographic Details
Published in:Journal of mathematical biology 2017-03, Vol.74 (4), p.809-841
Main Authors: Fermin, Lisandro J., Lévy Véhel, Jacques
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113
cites cdi_FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113
container_end_page 841
container_issue 4
container_start_page 809
container_title Journal of mathematical biology
container_volume 74
creator Fermin, Lisandro J.
Lévy Véhel, Jacques
description We propose a stochastic model for the drug concentration in the case of multiple oral doses and in a situation of poor patient adherence. Our model is able to take into account an irregular drug intake schedule. This article is the second in a series of three. It presents a multi-oral version of the results given in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39, 2013 ), that dealt with the multi-IV bolus case. Under the assumption that the irregular dosing schedule follows a Poisson law, we study features of the drug concentration that have practical implications, such as its variability and the regularity of its cumulative probability distribution, which describes its predictive power with respect to the mean behaviour. We consider four variants: continuous-time, with either deterministic or random doses, and discrete-time, also with either deterministic or random doses. Our computations allow one to assess in a precise way the effect of various significant parameters such as the mean rate of intake, the elimination rate, the absorption rate and the mean dose. They quantify how much poor adherence will affect the efficacy of therapy. To appreciate this impact, we provide detailed comparisons with the variability of concentration in two reference situations: a fully adherent patient and a population of fully adherent patients with log-normally distributed pharmacokinetic parameters. Besides, the discrete-time versions of our models reveal unexpected links with objects which have been studied in the mathematical literature under the name of infinite Bernoulli convolutions (Erdós, Am J Math 61:974-975, 1939 ). This allows us to quantify the fact that, when the random dosing schedule is too sparse, the concentration behaves in a very erratic way. Our results complement the ones in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39, 2013 ) and help understanding the consequences of poor adherence. They may have practical outcomes in terms of drug dosing and scheduling.
doi_str_mv 10.1007/s00285-016-1041-1
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00868621v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4313379501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113</originalsourceid><addsrcrecordid>eNp1kcFu1DAQhi0EotuFB-CCLHGBQ2DGdmKHW1VBu9JKXICr5ThO160TBzup1LcnUUqFkDhZM_78z1gfIW8QPiKA_JQBmCoLwKpAEFjgM7JDwVmBAqvnZAcceFEpZGfkPOdbAJRljS_JGZOCo5LVjtz9NMmbxgc_PVAztDT74WYOS3Otk19L2qXY0zHGRG3sx-DNYB31AzV0PJnUGxvv_OAmb2kfWxfo4fCZTidH-zlMvojJBGpNdq_Ii86E7F4_nnvy4-uX75fXxfHb1eHy4lhYIeqpKDtb25K3nZPAuUBlrIOqbG3TMNk4qURdSpSdsqzpGqlqA8yUDet4ya1A5HvyYcs9maDH5HuTHnQ0Xl9fHPXaA1CVqhjer-z7jR1T_DW7POneZ-tCMIOLc9aoWCVZDUv2nrz7B72NcxqWnyxUJWsOgouFwo2yKeacXPe0AYJerenNml6s6dWaXpd4-5g8N71rn1780bQAbAPycjXcuPTX6P-m_gZeRaEq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1867930434</pqid></control><display><type>article</type><title>Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case</title><source>Springer Link</source><creator>Fermin, Lisandro J. ; Lévy Véhel, Jacques</creator><creatorcontrib>Fermin, Lisandro J. ; Lévy Véhel, Jacques</creatorcontrib><description>We propose a stochastic model for the drug concentration in the case of multiple oral doses and in a situation of poor patient adherence. Our model is able to take into account an irregular drug intake schedule. This article is the second in a series of three. It presents a multi-oral version of the results given in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39, 2013 ), that dealt with the multi-IV bolus case. Under the assumption that the irregular dosing schedule follows a Poisson law, we study features of the drug concentration that have practical implications, such as its variability and the regularity of its cumulative probability distribution, which describes its predictive power with respect to the mean behaviour. We consider four variants: continuous-time, with either deterministic or random doses, and discrete-time, also with either deterministic or random doses. Our computations allow one to assess in a precise way the effect of various significant parameters such as the mean rate of intake, the elimination rate, the absorption rate and the mean dose. They quantify how much poor adherence will affect the efficacy of therapy. To appreciate this impact, we provide detailed comparisons with the variability of concentration in two reference situations: a fully adherent patient and a population of fully adherent patients with log-normally distributed pharmacokinetic parameters. Besides, the discrete-time versions of our models reveal unexpected links with objects which have been studied in the mathematical literature under the name of infinite Bernoulli convolutions (Erdós, Am J Math 61:974-975, 1939 ). This allows us to quantify the fact that, when the random dosing schedule is too sparse, the concentration behaves in a very erratic way. Our results complement the ones in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39, 2013 ) and help understanding the consequences of poor adherence. They may have practical outcomes in terms of drug dosing and scheduling.</description><identifier>ISSN: 0303-6812</identifier><identifier>EISSN: 1432-1416</identifier><identifier>DOI: 10.1007/s00285-016-1041-1</identifier><identifier>PMID: 27431876</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Applications of Mathematics ; Drug Administration Schedule ; Humans ; Mathematical and Computational Biology ; Mathematics ; Mathematics and Statistics ; Models, Theoretical ; Patient Compliance ; Pharmacokinetics ; Probability</subject><ispartof>Journal of mathematical biology, 2017-03, Vol.74 (4), p.809-841</ispartof><rights>Springer-Verlag Berlin Heidelberg 2016</rights><rights>Journal of Mathematical Biology is a copyright of Springer, 2017.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113</citedby><cites>FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113</cites><orcidid>0000-0003-2645-8231</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27431876$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inria.hal.science/hal-00868621$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Fermin, Lisandro J.</creatorcontrib><creatorcontrib>Lévy Véhel, Jacques</creatorcontrib><title>Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case</title><title>Journal of mathematical biology</title><addtitle>J. Math. Biol</addtitle><addtitle>J Math Biol</addtitle><description>We propose a stochastic model for the drug concentration in the case of multiple oral doses and in a situation of poor patient adherence. Our model is able to take into account an irregular drug intake schedule. This article is the second in a series of three. It presents a multi-oral version of the results given in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39, 2013 ), that dealt with the multi-IV bolus case. Under the assumption that the irregular dosing schedule follows a Poisson law, we study features of the drug concentration that have practical implications, such as its variability and the regularity of its cumulative probability distribution, which describes its predictive power with respect to the mean behaviour. We consider four variants: continuous-time, with either deterministic or random doses, and discrete-time, also with either deterministic or random doses. Our computations allow one to assess in a precise way the effect of various significant parameters such as the mean rate of intake, the elimination rate, the absorption rate and the mean dose. They quantify how much poor adherence will affect the efficacy of therapy. To appreciate this impact, we provide detailed comparisons with the variability of concentration in two reference situations: a fully adherent patient and a population of fully adherent patients with log-normally distributed pharmacokinetic parameters. Besides, the discrete-time versions of our models reveal unexpected links with objects which have been studied in the mathematical literature under the name of infinite Bernoulli convolutions (Erdós, Am J Math 61:974-975, 1939 ). This allows us to quantify the fact that, when the random dosing schedule is too sparse, the concentration behaves in a very erratic way. Our results complement the ones in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39, 2013 ) and help understanding the consequences of poor adherence. They may have practical outcomes in terms of drug dosing and scheduling.</description><subject>Applications of Mathematics</subject><subject>Drug Administration Schedule</subject><subject>Humans</subject><subject>Mathematical and Computational Biology</subject><subject>Mathematics</subject><subject>Mathematics and Statistics</subject><subject>Models, Theoretical</subject><subject>Patient Compliance</subject><subject>Pharmacokinetics</subject><subject>Probability</subject><issn>0303-6812</issn><issn>1432-1416</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kcFu1DAQhi0EotuFB-CCLHGBQ2DGdmKHW1VBu9JKXICr5ThO160TBzup1LcnUUqFkDhZM_78z1gfIW8QPiKA_JQBmCoLwKpAEFjgM7JDwVmBAqvnZAcceFEpZGfkPOdbAJRljS_JGZOCo5LVjtz9NMmbxgc_PVAztDT74WYOS3Otk19L2qXY0zHGRG3sx-DNYB31AzV0PJnUGxvv_OAmb2kfWxfo4fCZTidH-zlMvojJBGpNdq_Ii86E7F4_nnvy4-uX75fXxfHb1eHy4lhYIeqpKDtb25K3nZPAuUBlrIOqbG3TMNk4qURdSpSdsqzpGqlqA8yUDet4ya1A5HvyYcs9maDH5HuTHnQ0Xl9fHPXaA1CVqhjer-z7jR1T_DW7POneZ-tCMIOLc9aoWCVZDUv2nrz7B72NcxqWnyxUJWsOgouFwo2yKeacXPe0AYJerenNml6s6dWaXpd4-5g8N71rn1780bQAbAPycjXcuPTX6P-m_gZeRaEq</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Fermin, Lisandro J.</creator><creator>Lévy Véhel, Jacques</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><general>Springer</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>M7Z</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0003-2645-8231</orcidid></search><sort><creationdate>20170301</creationdate><title>Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case</title><author>Fermin, Lisandro J. ; Lévy Véhel, Jacques</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Applications of Mathematics</topic><topic>Drug Administration Schedule</topic><topic>Humans</topic><topic>Mathematical and Computational Biology</topic><topic>Mathematics</topic><topic>Mathematics and Statistics</topic><topic>Models, Theoretical</topic><topic>Patient Compliance</topic><topic>Pharmacokinetics</topic><topic>Probability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fermin, Lisandro J.</creatorcontrib><creatorcontrib>Lévy Véhel, Jacques</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Database‎ (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Biochemistry Abstracts 1</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Journal of mathematical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fermin, Lisandro J.</au><au>Lévy Véhel, Jacques</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case</atitle><jtitle>Journal of mathematical biology</jtitle><stitle>J. Math. Biol</stitle><addtitle>J Math Biol</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>74</volume><issue>4</issue><spage>809</spage><epage>841</epage><pages>809-841</pages><issn>0303-6812</issn><eissn>1432-1416</eissn><abstract>We propose a stochastic model for the drug concentration in the case of multiple oral doses and in a situation of poor patient adherence. Our model is able to take into account an irregular drug intake schedule. This article is the second in a series of three. It presents a multi-oral version of the results given in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39, 2013 ), that dealt with the multi-IV bolus case. Under the assumption that the irregular dosing schedule follows a Poisson law, we study features of the drug concentration that have practical implications, such as its variability and the regularity of its cumulative probability distribution, which describes its predictive power with respect to the mean behaviour. We consider four variants: continuous-time, with either deterministic or random doses, and discrete-time, also with either deterministic or random doses. Our computations allow one to assess in a precise way the effect of various significant parameters such as the mean rate of intake, the elimination rate, the absorption rate and the mean dose. They quantify how much poor adherence will affect the efficacy of therapy. To appreciate this impact, we provide detailed comparisons with the variability of concentration in two reference situations: a fully adherent patient and a population of fully adherent patients with log-normally distributed pharmacokinetic parameters. Besides, the discrete-time versions of our models reveal unexpected links with objects which have been studied in the mathematical literature under the name of infinite Bernoulli convolutions (Erdós, Am J Math 61:974-975, 1939 ). This allows us to quantify the fact that, when the random dosing schedule is too sparse, the concentration behaves in a very erratic way. Our results complement the ones in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39, 2013 ) and help understanding the consequences of poor adherence. They may have practical outcomes in terms of drug dosing and scheduling.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>27431876</pmid><doi>10.1007/s00285-016-1041-1</doi><tpages>33</tpages><orcidid>https://orcid.org/0000-0003-2645-8231</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0303-6812
ispartof Journal of mathematical biology, 2017-03, Vol.74 (4), p.809-841
issn 0303-6812
1432-1416
language eng
recordid cdi_hal_primary_oai_HAL_hal_00868621v1
source Springer Link
subjects Applications of Mathematics
Drug Administration Schedule
Humans
Mathematical and Computational Biology
Mathematics
Mathematics and Statistics
Models, Theoretical
Patient Compliance
Pharmacokinetics
Probability
title Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T08%3A14%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Variability%20and%20singularity%20arising%20from%20poor%20compliance%20in%20a%20pharmacokinetic%20model%20II:%20the%20multi-oral%20case&rft.jtitle=Journal%20of%20mathematical%20biology&rft.au=Fermin,%20Lisandro%20J.&rft.date=2017-03-01&rft.volume=74&rft.issue=4&rft.spage=809&rft.epage=841&rft.pages=809-841&rft.issn=0303-6812&rft.eissn=1432-1416&rft_id=info:doi/10.1007/s00285-016-1041-1&rft_dat=%3Cproquest_hal_p%3E4313379501%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1867930434&rft_id=info:pmid/27431876&rfr_iscdi=true